东宝生物300239资产负债表 |
3749 ℃ |
|
当前股价：5.58，市值：33
亿，动态市盈率PE：36.44，
合理估值PE：15，未来三年预期收益率：-45.7%。 其中，历史营业增长率：15.04%，净利增长率：16.65%； 未来三年预估净利增长率：0% （24E:--%, 25E:--%, 26E:--%）。 |
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 货币资金(万) | 74869.14 | 35611.23 | 22587.03 | 4804.84 | 6620.23 | 9842.45 | 5438.24 | 14218.12 | 25490.41 | 5028.62 |
| 应收票据(万) | 8950.95 | 12304.16 | 10066.2 | - | - | 3806.15 | 2536.51 | 3738.01 | 2606.03 | 4222.46 |
| 应收账款(万) | 16202.9 | 14611.72 | 15044.77 | 9549.72 | 10228.86 | 9752.69 | 6892.77 | 4442.43 | 5332.06 | 3910.29 |
| 预付款项(万) | 769.59 | 1050.04 | 1147.73 | 846.21 | 617.17 | 574.89 | 468.54 | 277.25 | 1046.59 | 929.93 |
| 其他应收款(万) | 146.02 | 314.84 | 519.14 | 88.39 | 153.83 | 419.54 | 307.06 | 217.63 | 42.05 | 330.32 |
| 存货(万) | 28153.04 | 31783.6 | 34602.49 | 28656.26 | 23077.41 | 22947.13 | 15479.08 | 9706.62 | 12682.64 | 15820.08 |
| 划分为持有待售的资产(万) | - | - | - | - | - | 269.89 | - | - | - | - |
| 一年内到期的非流动资产(万) | - | - | - | - | - | - | - | 150.41 | 136.49 | - |
| 其他流动资产(万) | 730.9 | 50.8 | 156.36 | 456.05 | - | 107.36 | 162.87 | 95.69 | 0.56 | - |
| 流动资产合计(万) | 134960.31 | 102389.08 | 89259.29 | 48257.66 | 47252.67 | 47720.11 | 31285.07 | 32846.17 | 47336.83 | 30241.71 |
| 可供出售金融资产(万) | - | - | - | - | - | 180 | 180 | 180 | - | - |
| 长期股权投资(万) | 1882.58 | 2269.45 | 2926.08 | 2522.09 | 2116.71 | 694.33 | 400.4 | 229 | - | - |
| 投资性房地产(万) | 3463.91 | 3644.14 | 1594.22 | - | - | - | - | - | - | - |
| 固定资产净额(万) | 79784.94 | 85879.14 | 87280.49 | 73828.07 | 61913.47 | 47116.84 | 49240.77 | 18475.04 | 20010.61 | 20692.34 |
| 在建工程(万) | 36493.63 | 16029.23 | 9409.59 | 7375.55 | 12257.24 | 16556.22 | 8240.43 | 23671.48 | 3302.77 | 171.05 |
| 工程物资(万) | - | - | - | - | - | - | - | - | - | - |
| 无形资产(万) | 14484.24 | 15213.54 | 17459.97 | 7805.3 | 6439.68 | 6537.83 | 7173.95 | 7204.93 | 5918.08 | 710.2 |
| 开发支出(万) | 323.82 | 203.54 | 773.7 | 560.6 | 215.93 | 253.88 | 251.88 | 348.71 | 1191.65 | 936.24 |
| 长期待摊费用(万) | 320.55 | 259.87 | 172.45 | - | - | - | 17.54 | 17.54 | 39.27 | 134.68 |
| 递延所得税资产(万) | 1364.63 | 1184.48 | 1067.31 | 1079.75 | 796.09 | 815.13 | 363.49 | 340.37 | 205.13 | 170.75 |
| 其他非流动资产(万) | 560.36 | 3176.73 | 718.8 | 184.4 | - | - | - | - | - | - |
| 非流动资产合计(万) | 139240.81 | 128422.28 | 121964.76 | 93535.76 | 84182.11 | 72154.21 | 65868.47 | 50467.06 | 30667.5 | 22815.25 |
| 资产总计(万) | 274201.12 | 230811.36 | 211224.05 | 141793.42 | 131434.78 | 119874.32 | 97153.54 | 83313.23 | 78004.33 | 53056.96 |
| 短期借款(万) | 584.05 | 207.07 | 5051.63 | 9091.68 | 1100.76 | 4000 | - | - | - | - |
| 应付票据(万) | 6129 | 2960.5 | 5014 | - | 3400 | 7467 | - | - | - | - |
| 应付账款(万) | 12602.66 | 9518.06 | 9144.64 | 15618.66 | 14376.76 | 20768.53 | 17280.65 | 7535.35 | 3473.74 | 5104.66 |
| 预收款项(万) | - | - | - | - | 1198.14 | 402.08 | 439.22 | 465.48 | 332.85 | 138.56 |
| 应付职工薪酬(万) | 1089.84 | 919.09 | 640.82 | 295.01 | 213.08 | 190.92 | 151.52 | 99.73 | 64.2 | 42.41 |
| 应交税费(万) | 1127.44 | 1501.18 | 1323.28 | 648.71 | 334.6 | 730.43 | 158.19 | 258.54 | 145.75 | 185.52 |
| 应付利息(万) | - | - | - | - | - | 10.13 | 4.22 | - | - | 342.22 |
| 应付股利(万) | - | - | - | - | - | - | - | - | - | - |
| 其他应付款(万) | 1230.84 | 1365.72 | 13416.21 | 435.72 | 647.28 | 949.57 | 101.8 | 95.19 | 1168.69 | 86.27 |
| 一年内到期的非流动负债(万) | 61.97 | 4101.69 | - | 1904.31 | 3056.23 | 1640.67 | 320 | - | - | 10920.69 |
| 其他流动负债(万) | 6566.1 | 9623.64 | 7068.41 | 5894.92 | - | 277.27 | 723.7 | 141.55 | 141.55 | 130.84 |
| 流动负债合计(万) | 30093.53 | 31625.56 | 42138.65 | 34964.67 | 24326.85 | 36436.6 | 19179.3 | 8595.85 | 5326.78 | 16951.18 |
| 长期借款(万) | 4476.67 | 15200 | - | 800 | 2700 | 1550 | 2400 | - | - | - |
| 应付债券(万) | 41805.61 | - | - | - | - | - | - | - | - | - |
| 长期应付款(万) | 1000 | 1000 | 1000 | 1000 | 1000 | 2296.17 | 1000 | 1000 | 1000 | 1000 |
| 专项应付款(万) | - | - | - | - | - | - | - | - | - | - |
| 预计非流动负债(万) | - | - | - | - | - | 186.56 | - | - | - | - |
| 递延所得税负债(万) | 2990.3 | 2533.58 | 2755.64 | - | - | - | - | - | - | - |
| 长期递延收益(万) | 4515.71 | 4866.68 | 4963.78 | 5210.43 | 4221.48 | 4317.04 | 1598.75 | 1831.38 | 1022.93 | 1050.2 |
| 其他非流动负债(万) | - | - | - | - | - | - | - | - | - | - |
| 非流动负债合计(万) | 54788.29 | 23600.26 | 8719.42 | 7010.43 | 7921.48 | 8349.77 | 4998.75 | 2831.38 | 2022.93 | 2050.2 |
| 负债合计(万) | 84881.82 | 55225.82 | 50858.07 | 41975.1 | 32248.34 | 44786.37 | 24178.06 | 11427.23 | 7349.71 | 19001.38 |
| 实收资本(或股本)(万) | 59360.3 | 59360.3 | 59360.3 | 52181.01 | 52274.61 | 46399.41 | 46087.41 | 46087.41 | 23043.71 | 19754.8 |
| 资本公积(万) | 63582.13 | 63582.14 | 63588.01 | 31395.74 | 31754.12 | 15857.76 | 15226.87 | 15226.87 | 38270.58 | 5154.31 |
| 减：库存股(万) | - | - | - | 253.66 | 507.31 | 845.52 | - | - | - | - |
| 盈余公积(万) | 5872.72 | 4756.07 | 3710.83 | 3309.67 | 3160.13 | 2855.37 | 2560.43 | 2335.53 | 2135.78 | 2050.71 |
| 未分配利润(万) | 34480.99 | 25152.47 | 15610.14 | 12362.89 | 12504.9 | 10820.92 | 9100.77 | 8236.19 | 7204.55 | 7095.76 |
| 归属于母公司股东权益合计(万) | 165806.17 | 152850.98 | 142269.28 | 98995.65 | 99186.44 | 75087.95 | 72975.48 | 71886 | 70654.62 | 34055.58 |
| 少数股东权益(万) | 23513.14 | 22734.56 | 18096.7 | 822.67 | - | - | - | - | - | - |
| 所有者权益(或股东权益)合计(万) | 189319.3 | 175585.54 | 160365.98 | 99818.32 | 99186.44 | 75087.95 | 72975.48 | 71886 | 70654.62 | 34055.58 |
| 负债和所有者权益(或股东权益)总计(万) | 274201.12 | 230811.36 | 211224.05 | 141793.42 | 131434.78 | 119874.32 | 97153.54 | 83313.23 | 78004.33 | 53056.96 |
| 应收票据及应收账款(万) | 25153.85 | 26915.88 | 25110.98 | 9549.72 | 10228.86 | - | - | - | - | - |
| 应收款项融资(万) | 5137.78 | 6662.7 | 5135.56 | 3856.2 | 6555.15 | - | - | - | - | - |
| 其他应收款(合计)(万) | 146.02 | 314.84 | 519.14 | 88.39 | 153.83 | - | - | - | - | - |
| 在建工程(合计)(万) | 36493.63 | 16029.23 | 9409.59 | 7375.55 | 12257.24 | - | - | - | - | - |
| 固定资产及清理(合计)(万) | 79784.94 | 85879.14 | 87280.49 | 73828.07 | 61913.47 | - | - | - | - | - |
| 应付票据及应付账款(万) | 18731.66 | 12478.56 | 14158.64 | 15618.66 | 17776.76 | - | - | - | - | - |
| 其他应付款(合计)(万) | 1230.84 | 1365.72 | 13416.21 | 435.72 | 647.28 | - | - | - | - | - |
| 长期应付款(合计)(万) | 1000 | 1000 | 1000 | 1000 | 1000 | - | - | - | - | - |